Ikapharmindo Putramas Tbk. (IKPM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ikapharmindo Putramas Tbk. (IKPM) has a cash flow conversion efficiency ratio of -0.005x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-1.14 Billion ≈ $-66.85K USD) by net assets (Rp236.96 Billion ≈ $13.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Ikapharmindo Putramas Tbk. stock valuation for the company's overall valuation and market capitalisation.
Ikapharmindo Putramas Tbk. - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Ikapharmindo Putramas Tbk.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ikapharmindo Putramas Tbk. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ikapharmindo Putramas Tbk. ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Ikapharmindo Putramas Tbk. to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ortivus AB ser. B
ST:ORTI-B
|
-0.529x |
|
Stuve Gold Corp
V:STUV
|
0.064x |
|
Wooyang Co. Ltd
KQ:103840
|
0.087x |
|
UMS-Neiken Group Bhd
KLSE:7227
|
0.019x |
|
Dalaroo Metals Ltd
AU:DAL
|
-0.433x |
|
WindowMaster International AS
CO:WMA
|
-0.019x |
|
CXApp Inc.
NASDAQ:CXAI
|
-0.139x |
|
Sung Gang Asset Management Ltd
TWO:6240
|
0.016x |
Annual Cash Flow Conversion Efficiency for Ikapharmindo Putramas Tbk. (2022–2024)
The table below shows the annual cash flow conversion efficiency of Ikapharmindo Putramas Tbk. from 2022 to 2024. View Ikapharmindo Putramas Tbk. stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp246.12 Billion ≈ $14.42 Million |
Rp-33.68 Billion ≈ $-1.97 Million |
-0.137x | -229.09% |
| 2023-12-31 | Rp244.71 Billion ≈ $14.34 Million |
Rp25.94 Billion ≈ $1.52 Million |
0.106x | +399.21% |
| 2022-12-31 | Rp176.70 Billion ≈ $10.35 Million |
Rp3.75 Billion ≈ $219.86K |
0.021x | -- |
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and… Read more